Department of Surgery, Federal University of Pernambuco, Recife, Pernambuco, Brazil.
Medical School, Federal University of Pernambuco, Recife, Pernambuco, Brazil.
Surg Infect (Larchmt). 2020 Oct;21(8):654-658. doi: 10.1089/sur.2019.275. Epub 2020 Feb 28.
When patients with significant comorbid risk factors undergo surgical procedures, they are at high risk for development of post-operative infectious complications, including surgical site infection (SSI). Obese patients characteristically fit within this risk category, and thus it is of paramount importance to establish evidence-based strategies to mitigate these infectious complications. The use of an antimicrobial prophylactic regimen is a well-established practice and is based on the principle of the "right drug, at the right time, in the right place." The subject of this article is to review the current evidence-based data on antimicrobial prophylaxis in obese patients undergoing bariatric surgical procedures.
当存在重大合并症风险因素的患者接受手术时,他们发生术后感染性并发症(包括手术部位感染 [SSI])的风险很高。肥胖患者通常属于这一风险类别,因此,制定基于循证的策略来减轻这些感染性并发症至关重要。使用预防性抗菌方案是一种既定的做法,其基于“正确的药物、在正确的时间、在正确的部位”的原则。本文的主题是回顾肥胖患者接受减重手术时预防性使用抗菌药物的循证数据。